Atara Biotherapeutics, Inc. (Nasdaq: ATRA) announced that its collaborating investigators at Memorial Sloan Kettering Cancer Center (MSK) are reporting Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE